PT - JOURNAL ARTICLE AU - Baral, Stefan AU - Rao, Amrita AU - Twahirwa Rwema, Jean Olivier AU - Lyons, Carrie AU - Cevik, Muge AU - Kågesten, Anna E. AU - Diouf, Daouda AU - Sohn, Annette H. AU - Phaswana-Mafuya, Refilwe AU - Kamarulzaman, Adeeba AU - Millett, Gregorio AU - Marcus, Julia L. AU - Mishra, Sharmistha TI - Competing Health Risks Associated with the COVID-19 Pandemic and Response: A Scoping Review AID - 10.1101/2021.01.07.21249419 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.07.21249419 4099 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249419.short 4100 - http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249419.full AB - Background COVID-19 has rapidly emerged as a global public health threat with infections recorded in nearly every country. Responses to COVID-19 have varied in intensity and breadth, but generally have included domestic and international travel limitations, closure of non-essential businesses, and repurposing of health services. While these interventions have focused on testing, treatment, and mitigation of COVID-19, there have been reports of interruptions to diagnostic, prevention, and treatment services for other public health threats. We conducted a scoping review to characterize the impact of COVID-19 on HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.Methods A scoping literature review was completed using searches of PubMed and preprint servers (medRxiv/bioRxiv) from January 1st to October 31st, 2020, using Medical Subject Headings (MeSH) terms related to SARS-CoV-2 or COVID-19 and HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition. Empiric studies reporting original data collection and mathematical models were included, and available data synthesized by region. Studies were excluded if they were not written in English.Results A total of 1604 published papers and 205 preprints met inclusion criteria, including 8.2% (132/1604) of published studies and 10.2% (21/205) of preprints: 7.3% (68/931) on HIV, 7.1% (24/339) on tuberculosis, 11.6% (26/224) on malaria, 7.8% (13/166) on sexual and reproductive health, and 12.1% (16/132) on malnutrition. Thematic results were similar across competing health risks, with substantial indirect effects of the COVID-19 pandemic and response on diagnostic, prevention, and treatment services for HIV, tuberculosis, malaria, sexual and reproductive health, and malnutrition.Discussion COVID-19 emerged in the context of existing public health threats that result in millions of deaths every year. Thus, effectively responding to COVID-19 while minimizing the negative impacts of COVID-19 necessitates innovation and integration of existing programs that are often siloed across health systems. Inequities have been a consistent driver of existing health threats; COVID-19 has worsened disparities, reinforcing the need for programs that address structural risks. Data reviewed here suggest that effective strengthening of health systems should include investment in public health with adequate funding to ensure continuity of care for emergent and existing public health threats.Competing Interest StatementAnnette Sohn and Gregorio Millett report funding from Viiv. Julia Marcus has consulted in the past for Kaiser Permanente Northern California on a research grant from Gilead Sciences. All other authors report no competing interests. Funding StatementAmrita Rao is supported in part by the National Institute of Mental Health [F31MH124458]. Julia Marcus is supported in part by the National Institute of Allergy and Infectious Diseases [K01AI122853].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:We conducted a scoping literature review of published and preprint papers. No individual human subjects data was collected or accessed.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll articles cited in this scoping review are available and search strategies have been shared in the main document.